Dynamic Technology Lab Private LTD Zymeworks Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$4.82 - $7.7 $149,930 - $239,516	31,106 Added 102.85%	61,351 $325,000
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $181,470 - $513,560	30,245 New	30,245 $198,000
Q4 2021 Feb 14, 2022	SELL	$15.19 - $29.33 $144,153 - $278,341	-9,490 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $259,551 - $353,787	9,490 New	9,490 $276,000
Q2 2021 Aug 13, 2021	SELL	$26.5 - $38.23 $205,057 - $295,823	-7,738 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$29.83 - $56.81 $230,824 - $439,595	7,738 New	7,738 $244,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.